Month: March 2026

The agreement includes approximately 330,000 Medicare Advantage members and more than 1.7 million commercial members in California, significantly expanding Rocket Doctor’s in-network reach across the state. Eligible members gain access to Rocket Doctor’s network of board-certified physicians, delivering primary care, chronic disease management, preventive services, and coordinated follow-up through its digital health platform and marketplace. The agreement builds on Rocket Doctor’s January 27, 2026 announcement, which expanded access to additional commercial members across California.Vancouver, BC, March 24, 2026 (GLOBE NEWSWIRE) — Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI”) today announced that doctors using its wholly owned digital health platform and marketplace, Rocket Doctor Inc., are...

LAWRENCEVILLE, N.J., March 24, 2026 (GLOBE NEWSWIRE) — IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage company in Phase 3 development with its DNA-mediated immunotherapy, today announced that the Company will host a conference call at 11:00 a.m. EDT on Tuesday, March 31, 2026 to discuss financial results for the year ended December 31, 2025, and provide an update on its clinical development program with IMNN-001, a DNA-based interleukin-12 (IL-12) immunotherapy. The Company is hosting a conference call to review 2025 financial results and provide a business update on March 31, 2026 at 11:00 a.m. EDT. To participate in the call, please dial 800-715-9871 (North America/Toll Free) or 646-307-1963 (U.S./Toll) and ask for the IMUNON Year End 2025 Financial Results Call (Conference ID 4157104). A live webcast of the call will also be available here. An...

Additional analyses from the SCORED and SOTA-P-CARDIA studies provide further evidence of benefits across patient subgroups potentially related to sotagliflozin’s mechanism of action THE WOODLANDS, Texas, March 24, 2026 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced three presentations of sotagliflozin clinical data during the American College of Cardiology (ACC) Annual Meeting. The congress is being held March 28-30 in New Orleans, Louisiana. Lexicon will present data from the Phase 3 SCORED study of sotagliflozin in people with type 2 diabetes, chronic kidney disease and other cardiovascular risk factors. In a prespecified analysis, patients were stratified by baseline body mass index (BMI), and the results demonstrated that sotagliflozin reduced heart failure and major adverse cardiovascular...

Request omitted highly material disclosures required under the Company’s bylaws YZi Labs may not proceed with its proposed consent solicitation Stockholders are not required to take any action at this time LOUISVILLE, CO, March 24, 2026 (GLOBE NEWSWIRE) — CEA Industries Inc. (NASDAQ: BNC) (“BNC” or the “Company”) today announced that its Board of Directors (the “Board”) has completed its review of the request received from YZILabs Management Ltd. (“YZi Labs”) to set a record date for determining the stockholders entitled to consent in connection with YZi Labs’ proposed consent solicitation (the “Request Letter”). The Board has determined that YZi Labs’ Request Letter is deficient because it omitted material information required under the Company’s bylaws. Accordingly, the Board has not set a record date,...

AGOURA HILLS, Calif., March 24, 2026 (GLOBE NEWSWIRE) — Oncotelic Therapeutics, Inc. (OTCQB:OTLC) (“Oncotelic”, the “Company” or “We” or “Our”), a leader in RNA-based therapeutics, announced today that its subsidiary Sapu Nano will formally introduce its Deciparticle™ nanomedicine platform and present its advancing clinical pipeline at BIO-Europe Spring 2026, where the company has been selected as a Presenting Company. The presentation will take place at:Event: BIO-Europe Spring 2026 Session: Presenting Company Location: Theater A Date: March 25, 2026During the session, Sapu Nano will unveil its proprietary Deciparticle™ platform, a next-generation drug delivery technology engineered to optimize tissue distribution, enhance therapeutic index, and enable intravenous delivery...

RADNOR, Pa., March 24, 2026 (GLOBE NEWSWIRE) — Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone, announced the appointment of Jeffrey A. Munsie as Chief Legal Officer. “Jeff brings deep life sciences experience across critical stages of growth, from preclinical through commercialization,” said Jon Congleton, Chief Executive Officer of Mineralys. “His strategic counsel, strong leadership, and proven track record will be instrumental in strengthening our legal and compliance capabilities.” Mr. Munsie joins Mineralys with nearly 25 years of comprehensive legal experience in the biopharma industry. Most recently,...

VANCOUVER, British Columbia, March 24, 2026 (GLOBE NEWSWIRE) — Brixton Metals Corporation (TSX-V: BBB, OTCQX: BBBXF) (the “Company” or “Brixton”) announces that it has graduated and commenced trading on the OTCQX Best Market (“OTCQX”) under the ticker symbol “BBBXF”. Brixton’s common shares will continue to trade on the TSX Venture Exchange under the symbol “BBB”. The OTCQX is the top tier of OTC Markets and trading on the OTCQX is expected to enhance the visibility and accessibility to an expanded U.S. investor base. OTCQX listed companies must meet high financial standards, adhere to best practice corporate governance and demonstrate compliance with applicable securities laws. U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for Brixton Metals on www.otcmarkets.com. About Brixton Metals Corporation Brixton...

Goal of Expanding Into Global Exploration Market Company to introduce proprietary RF sensing technologies alongside conventional offshore discovery methods in Liberia Basin WEST HOLLYWOOD, Calif., March 24, 2026 (GLOBE NEWSWIRE) — VisionWave Holdings, Inc. (Nasdaq: VWAV) (“VisionWave” or the “Company”), a developer of advanced AI-driven sensing and radio-frequency (RF) technologies, today announced that it has entered into a Letter of Engagement (“LOE”) with the National Oil Company of Liberia (“NOCAL”) relating to offshore petroleum Blocks LB-4 and LB-5 in the Liberia Basin. The LOE provides VisionWave with an exclusive pathway to advance toward a potential Production Sharing Contract (“PSC”) with the Government of Liberia, subject to prequalification, regulatory approvals, and legislative ratification by the Liberian authorities. Positioning...

Char Coir Launches New Coco Coin Tray and Insert Tray to Improve Early-Stage Plant Development and Cultivation EfficiencyChar Coir Coin TrayCoco Coin TrayDENVER, March 24, 2026 (GLOBE NEWSWIRE) — GrowGeneration Corp. (NASDAQ: GRWG) (“GrowGeneration,” “GrowGen” or “the Company”), one of the nation’s largest suppliers of specialty products for controlled environment agriculture (CEA), commercial cultivation, and retail garden centers, today unveiled two new propagation products under the Char Coir brand, the Coco Coin Tray and the Insert Tray, offering gardeners, commercial growers, and greenhouse operators a modern, mess-free system for improved cultivation performance compared to traditional soil or peat-based methods. Built for both home gardeners and commercial cultivators, the new Char Coir Propagation System expands...

Role to Strengthen Engagement with Shareholders and Investment Community ISELIN, N.J., March 24, 2026 (GLOBE NEWSWIRE) — Provident Financial Services, Inc. (NYSE: PFS), the parent company of Provident Bank, announced today that Michael A. Perito has been appointed Head of Investor Relations. In this role, Mr. Perito will lead the company’s engagement with the investment community, including shareholders, equity research analysts, and industry stakeholders.Mr. Perito will continue to serve as Senior Vice President and Head of Corporate Strategy for Provident Bank, where he is responsible for helping guide the organization’s long-term strategic initiatives and growth priorities. “Mike brings a deep understanding of the banking industry, capital markets, and investor communications,” said Adriano Duarte, Executive Vice President...